Skip to content Skip to footer
Subscribe Now
Disease of the Month- Osteoporosis
INSIGHTS+

Disease of the Month- Osteoporosis

To keep our readers acquainted with several disease conditions, ongoing trials, and available treatment options, PharmaShots brings every month a detailed take on a particular disease after thorough research   Continuing the series for the disease of the month, PharmaShots brings a condensed report on Osteoporosis, a bone and tissue disorder  October 20th is observed as…
October 12, 2023

Read more

Thoughtspot_Haikle_lee_2023
THOUGHTSPOT

Understanding Selective Hearing Loss: Symptoms, Causes, and Treatment

Selective hearing loss, also known as selective auditory attention, is a condition in which an individual has difficulty hearing specific sounds or conversations, while still being able to hear other sounds normally. This type of hearing loss can cause significant communication problems, particularly in noisy environments, and can affect an individual's personal and professional life.…
May 19, 2023

Read more

Viewpoints_Jan van de Winkel
VIEWPOINTS

PharmaShots Interview: Genmab’s Jan van de Winkel Shares Insight on the Tivdak (tisotumab vedotin-tftv) for the Treatment of Recurrent or Metastatic Cervical Cancer

In an interview with PharmaShots, Jan van de Winkel, co-founder, President, and CEO at Genmab shared his views on the US FDA's Accelerated Approval of Tivdak (tisotumab vedotin-tftv) for the Treatment of Recurrent or Metastatic Cervical Cancer Shots: Genmab and Seagen have reported the US FDA's accelerated approval which is based on the P-II innovaTV 204 clinical trials evaluating tisotumab vedotin in…
November 15, 2021

Read more

Thoughtspot_Sunaina Anand
THOUGHTSPOT

Nutraceuticals Under Evaluation for COVID-19 Prevention and Treatment

The pandemic has led to the identification of some promising nutraceuticals for the management and prevention of Covid-19. Nutraceuticals with their immune-boosting potential can amplify the body's defense system against the virus. For the past numerous decades, the medicinal action of natural compounds has gained focus as an alternate or adjuvant therapy approach in treating…
June 24, 2021

Read more

ViewPoint_William_F_Doyle_2020
VIEWPOINTS

PharmaShots Interview: Novocure’s William F. Doyle Shares Insight on Company’s Accomplishments in the Treatment of Glioblastoma and Mesothelioma

In a recent interview with PharmaShots, William F. Doyle, Executive Chairman at Novocure shared information about the company's activities in the field of glioblastoma and mesothelioma. He also discussed the company's technology, Tumor Treating Fields (TTFields), and its potential for broad applicability across solid tumors. Shots: Novocure is a global oncology company working to extend survival…
December 9, 2020

Read more

Viewpoint_Brain Finrow_2020
VIEWPOINTS

PharmaShots Interview: Lumen’s Brian Finrow Shares Insight on Need for the Cheaper Methods to Engineer Antibodies as a Treatment for COVID-19

In an interview with PharmaShots, Brian Finrow, Co-Founder and CEO of Lumen Bioscience shared his views on the critical need for a scalable and cheaper method to engineer antibodies as a potential treatment for Covid-19. He also shed light on why it is time for the industry to reevaluate plant-based biologics manufacturing as a possible way to…
June 26, 2020

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]